Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Targeting tumor associated macrophages to alternate cancer stem cells and tumor microenvironment milieu

Universa Medicina · Vol. 45 No. 2 (2026) · hlm. 310–321

DOI
10.18051/UnivMed.2026.v45.310-321
ISSN
2407-2230, 1907-3062
Terbit
2026-08-22
Penerbit
Faculty of Medicine, Universitas Trisakti
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0

Abstrak

Macrophages in the tumor microenvironment are involved in promoting cancer growth and enabling it to evade therapies. By acting as something like a tumor's "underground," these cells dampen down the "calls for help" that chemotherapy or radiotherapy might otherwise trigger. They also appear to enable some cells in the cancers to reset themselves into cancer stem cells (CSCs), allowing them to divide and differentiate. Cancer stem cells are compelled to initiate tumors and maintain their growth. In part, the tumor-associated macrophages (TAMs) effect this by secreting cytokines with well-established roles in regulating stemness, as well as proteins that govern cell migration and are known to help keep CSCs in the niche where the tumor formed and maintain the tumor. Prognostic studies have found that TAMs are associated with worse patient outcomes. This article reviews the existing knowledge on TAMs in supporting the survival and maintenance of CSCs, increasing tumor resilience and resistance to therapy. We did a systematic review using the keywords CSC, TAM, tumor microenvironment (TME), and extracellular matrix remodeling from the following databases: ScienceDirect, PubMed, NCBI, Nature, Google Scholar, and Oxford Academic for articles published between 2010 to 2026. The underlying premise of the current investigation is that macrophages facilitate the maintenance of the "stemness" characteristics of CSCs. The TAM-CSC alliance must be interrupted to improve therapeutic outcomes and reduce tumor recurrence. Our review focuses on addressing the difficulties presented by CSCs and TME through advanced research techniques and specific combination treatments. This alternative method offers a less harsh and more effective therapy that will improve the patient’s outcomes by effectively eradicating tumor cells and modifying the tumor microenvironment to enhance the immune system's capability to combat the tumor.

Kata kunci

Jaringan kolaborasi para penulis

27 penulis · 99 tautan kepenulisan bersama · 50 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • University of Liverpool
  • University of Regensburg
  • Atma Jaya Catholic University of Indonesia
  • Dharmais Cancer Hospital
  • State University of Jakarta
  • Universitas Kristen Indonesia
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Mohamad SadikinUniversity of Indonesia3
Rini PuspitaningrumState University of Jakarta3
RONDANG ROEMIATI SOEGIANTOUniversitas Kristen Indonesia3
Arleni BustamiUniversity of Indonesia2
DARYL ROBERT WILLIAMSUniversity of Liverpool1
Andrew R. CossinsUniversity of Liverpool1
Sri HandayaniState University of Semarang1
Iman SantosoUniversity of Indonesia1
Hans‐Joachim FreislebenUniversity of Indonesia1
Harald HuberUniversity of Regensburg1
AndiUniversity of Indonesia1
Fery ArdiansyahUniversity of Indonesia1
Cenmi MulyantoUniversity of Indonesia1
Zessinda LuthfaUniversity of Indonesia1
Rosari SalehUniversity of Indonesia1
Seruni K.U. FreislebenUniversity of Indonesia1
Michael ThommUniversity of Regensburg1
Reni ParamitaUniversity of Indonesia1
Hastuti Handayani S PurbaNational Research and Innovation Agency1
Ani Retno PrijantiUniversity of Indonesia1
Maria Dara Novi HandayaniAtma Jaya Catholic University of Indonesia1
Parwati Abadi SoekarnoAtma Jaya Catholic University of Indonesia1
Sulfiana SulfianaUniversity of Indonesia1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://univmed.org/ejurnal/index.php/medicina/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Targeting tumor associated macrophages to alternate cancer stem cells and tumor microenvironment milieu</dc:title>
	<dc:creator xml:lang="en">Mahdaleny, Mahdaleny</dc:creator>
	<dc:creator xml:lang="en">Inawati Wanandi, Septelia </dc:creator>
	<dc:creator xml:lang="en">Sutandyo, Noorwati </dc:creator>
	<dc:creator xml:lang="en">Iswanti, Febriana Catur</dc:creator>
	<dc:subject xml:lang="en">immune cell</dc:subject>
	<dc:subject xml:lang="en">tumor microenvironment</dc:subject>
	<dc:subject xml:lang="en">epithelial-mesenchymal transition</dc:subject>
	<dc:subject xml:lang="en">infiltration</dc:subject>
	<dc:subject xml:lang="en">extracellular matrix remodeling</dc:subject>
	<dc:subject xml:lang="en">Tumor-associated macrophages</dc:subject>
	<dc:subject xml:lang="en">Cancer stem cells</dc:subject>
	<dc:subject xml:lang="en">Tumor microenvironment</dc:subject>
	<dc:subject xml:lang="en">Cancer immunology</dc:subject>
	<dc:subject xml:lang="en">Tumor plasticity</dc:subject>
	<dc:subject xml:lang="en">Immune modulation</dc:subject>
	<dc:description xml:lang="en">Macrophages in the tumor microenvironment are involved in promoting cancer growth and enabling it to evade therapies. By acting as something like a tumor's "underground," these cells dampen down the "calls for help" that chemotherapy or radiotherapy might otherwise trigger. They also appear to enable some cells in the cancers to reset themselves into cancer stem cells (CSCs), allowing them to divide and differentiate. Cancer stem cells are compelled to initiate tumors and maintain their growth. In part, the tumor-associated macrophages (TAMs) effect this by secreting cytokines with well-established roles in regulating stemness, as well as proteins that govern cell migration and are known to help keep CSCs in the niche where the tumor formed and maintain the tumor. Prognostic studies have found that TAMs are associated with worse patient outcomes. This article reviews the existing knowledge on TAMs in supporting the survival and maintenance of CSCs, increasing tumor resilience and resistance to therapy. We did a systematic review using the keywords CSC, TAM, tumor microenvironment (TME), and extracellular matrix remodeling from the following databases: ScienceDirect, PubMed, NCBI, Nature, Google Scholar, and Oxford Academic for articles published between 2010 to 2026. The underlying premise of the current investigation is that macrophages facilitate the maintenance of the "stemness" characteristics of CSCs. The TAM-CSC alliance must be interrupted to improve therapeutic outcomes and reduce tumor recurrence. Our review focuses on addressing the difficulties presented by CSCs and TME through advanced research techniques and specific combination treatments. This alternative method offers a less harsh and more effective therapy that will improve the patient’s outcomes by effectively eradicating tumor cells and modifying the tumor microenvironment to enhance the immune system's capability to combat the tumor.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Universitas Trisakti</dc:publisher>
	<dc:date>2026-08-22</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://univmed.org/ejurnal/index.php/medicina/article/view/1961</dc:identifier>
	<dc:identifier>10.18051/UnivMed.2026.v45.310-321</dc:identifier>
	<dc:source xml:lang="en">Universa Medicina; Vol. 45 No. 2 (2026); 310-321</dc:source>
	<dc:source>2407-2230</dc:source>
	<dc:source>1907-3062</dc:source>
	<dc:source>10.18051/UnivMed.2026.v45.i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://univmed.org/ejurnal/index.php/medicina/article/view/1961/885</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Mahdaleny Mahdaleny, Septelia  Inawati Wanandi, Noorwati  Sutandyo, Febriana Catur Iswanti</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc-sa/4.0</dc:rights>
</oai_dc:dc>